According to CASI Pharmaceuticals's latest financial reports the company's current earnings are โฌ23.1 Million. In 2023 the company made an earning of -โฌ25.05 Million, an increase over its 2022 earnings that were of -โฌ35.55 Million. The earnings displayed on this page is the company's Pretax Income.